期刊文献+

比索洛尔联用贝那普利对慢性心力衰竭患者左室重构和心功能的影响 被引量:4

Effects of bisoprolol combined with benazepril on patients with chronic heart failure of left ventricular remodeling and cardiac function
暂未订购
导出
摘要 目的 评价比索洛尔与贝那普利治疗慢性充血性心力衰竭(CHF)的临床疗效.方法 将285例CHF患者随机分为3组(均给予常规强心、利尿、扩血管治疗):比索洛尔治疗组102例,贝那普利治疗组75例,比索洛尔与贝那普利组108例,观察三组治疗前后SBP、DBP、心率(HR)、左心室收缩末内径(LVESd)、左心室舒张末内径(LVEDd)及左心室射血分数(LVEF)的变化.结果 联合治疗组显效率和总有效率(75.3%和96.8%)均高于比索洛尔组(59.3%和82.7%,P<0.05)和贝那普利组(61.1%和81.9%,P<0.05),无效率(3.2%)显著低于比索洛尔组(17.3%,P<0.01)和贝那普利组(18.1%,P<0.01).治疗前后三组患者HR、SBP及DBP均有改善(P<0.05),联合治疗组较另外两组改善更明显(P<0.01).治疗前后三组LVEDd、LVESd及LVEF均显著改善(P<0.05),联合治疗组较另外两组改善明显.结论 比索洛尔治疗CHF的临床疗效与贝那普利相当,两者联合应用与单独使用相比,前者不仅能更好地提高疗效,而且安全有效. Objective To explore the clinical efficacy of bisoprolol combined with Benazepril on chronic congestive heart failure. Methods 285 cases of CHF were randomly divided into 3 groups: 102 patients treated with bisoprolol, benazepril 75 patients, bisoprolol combined with benazepril group of 108 cases. Observed three groups changes of SBP, DBP, heart rate, left ventrieular end-systolic diameter (LVESd), left ventricular end di- astolic diameter (LVEDd) and left ventricular ejection fraction (LVEF). Results The efficiency and total effi- ciency (75.3% and 96.8%) in combined treatment group were higher than bisoprolol group (59.3% and 82.7%, P〈0.05) and the benazepril group (61.1% and 81.9%, P〈0.05), inefficient (3.2%) was significantly lower than the bisoprolol group (17.3%, P〈0.O1 ) and the benazepril group (18.1%, P〈0.O1 ). Three groups of patients be- fore and after treatment heart rate, SBP and DBP were improved (P〈0.05), combined treatment group improved more significantly than the other two groups (P〈0.01). Three groups before and after treatment LVEDd, LVESd and LVEF were significantly improved (P〈O.05), combined treatment group improved significantly than in the oth- er two groups. Condusion Administration of bisoprolol plus benazepfil can significantly improve the clinical symptoms and cardiac function in patients with CHF,which is mole effective than the single benazepril or benazepril on the treatment. It can improve the prognosis and be used for the routine treatment of CHF.
出处 《中国心血管病研究》 CAS 2011年第2期118-121,共4页 Chinese Journal of Cardiovascular Research
关键词 心力衰竭 比索洛尔 贝那普利 心室重构 Chronic heart failure Bisoprolol Benazepril Ventrieular remodeling
  • 相关文献

参考文献7

二级参考文献25

  • 1王锋,于芳.比索洛尔对轻中度高血压心率及心率变异性的影响[J].中国基层医药,2006,13(1):48-49. 被引量:4
  • 2Lechat P. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled,randomized trials[J]. Circulation, 1998,98 ( 6 ) : 1184-1186.
  • 3[1]Waagstein F,Caidahl K,Wallentin I,et al. Long- term beta - blockde in dilated cardiomyopathy. Effecs of short and long- term metoprolol treatment followed bywithdrawal and readministration of metoprolol [ J ].Circulation, 1989,80: 551
  • 4[2]Waagstei F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprololin idiopathic dilate cardiomyopathy. Metoprolol in Dilated Cardiomyopathy(MDC)Trial Study GrouP[ J ]. Lancet, 1993,342:1441
  • 5[3]Lechat P. Beta - blockde treatment in heart failure:The cardiac insufficiency bisoprolol study(C1BIS) project[J ]. J Cardiovadc Pharmacol, 1990,16:158
  • 6[4]陈修心血管药理学[M].北京:人民卫生出版社,1998:173
  • 7[1]Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Guidelines for the evaluation and management of heart failure[J]. J Am Coll Cardiol, 1995, 26:1376- 1398
  • 8[2]MERIT - HF study Group. Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure [J]. Lancet, 1999, 353: 2001 - 2007
  • 9[3]Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure[ J ]. J Am Coll Cardiol, 1992, 20:248 - 254
  • 10[5]Flather MD, Yusuf S, Pfeffer M, et al. Long term ACE - inhibitor therapy with heart failure or left ventricular dysfunction: a systemic overview of data from individual patients[ J ]. Lancet, 2000, 355:1575 - 1581

共引文献3636

同被引文献35

  • 1邵鹏,张卫泽,陈永清,马凌.血管紧张素Ⅱ对大鼠心室Cx43重构的影响及贝那普利的干预作用[J].中国心血管病研究,2007,5(7):541-543. 被引量:2
  • 2Dickhout JG,Lee RM.Structural and functional analysis of small arteries from young spontaneously hypertensive rats.Hypertension,1997,29:781-789.
  • 3Intengan HD,Schiffrin EL.Vascular remodeling in hypertension:roles of apoptosis,inflammation and fibrosis.Hypertension,2001,38:581-587.
  • 4Wang P,Tang FT,Li RF,et al.Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats:Effect of valsartan.Pharma Cological Research,2007,55:408-417.
  • 5Skaletz-Rorowski A,Eschert H,Leng J,et al.PKC delta-induced activation of MAPK pathway is required for b-FGF-stimulated proliferation of coronary smooth muscle cells.Cardiovasc Res,2005,67:142-150.
  • 6Neary JT,Kang Y,Shi YF.Cell cycle regulation of astrocytes by extracellular nucleotides and fibroblast growth factor-2.Purinergic Signal,2005,1:329-336.
  • 7Frederick TJ,Min J,A1tieri SC,et al.Synergistic induction of cyclin D1 in oligodendrocyte progenitor cells by IGF-I and FGF-2 requires differential stimulation of multiple signaling pathways.Glia,2007,55:1011-1022.
  • 8Pratsinis H,Kletsas D.PDGF,bFGF and IGF-1 stimulate the proliferation of intervertebral disc cells vitro via the activation of the ERK and Akt signaling pathways.Eur Spine J,2007,16:1858-1866.
  • 9Schultz JE,Witt SA,Nieman ML,et al.Ang Ⅱ and fibroblast growth factor Mediat espressure-induced hypertrophic response.JC lin Invest,1999,104:709-719.
  • 10Borlaug BA,Lam CS,Roger VL. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction[J].Journal of the American College of Cardiology,2009,(05):410-418.doi:10.1016/j.jacc.2009.05.013.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部